P05.93 Adult medulloblastoma: analysis of use of chemotherapy in clinical practice

BACKGROUND: Adult medulloblastoma (MB) is rare, accounting for 150–300 new cases in the US annually. Given the low incidence, prospective studies are challenging, and the role of adjuvant chemotherapy in standard risk patients has been controversial. Currently, the best evidence available (Level V)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Mastall, M, Majd, N, Fuller, G, Gule-Monroe, M, Huse, J, Khatua, S, Rao, G, Sandberg, D, Wefel, J, Yeboa, D, Zaky, W, Mahajan, A, Puduvalli, V, Suki, D, Alfaro, K, Weathers, S, Harrison, R, de Groot, J, Penas-Prado, M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Poster Presentations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144716/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.419
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller